Appropriate Dose of Alfentanil to Inhibit Cardiovascular Autonomic Response Induced by Rapid Sequential Induction in Elderly Patients

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200062034

Enrollment

Unknown

Registered

2022-07-20

Start date

2022-07-15

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All kinds of disease

Interventions

four:alfentanil

Eligibility

Sex/Gender

All

Age

65 Years to 90 Years

Inclusion criteria

Inclusion criteria: Eligible study subjects were American Society of Anesthesiologists class ?-? patients Mallampati airway class 1 or 2, scheduled for elective surgery.

Exclusion criteria

Exclusion criteria: Exclusion criteria were as follows: age >90 or 28 kg/m2, presence of gastroesophageal reflux, use of medication known to interfere with cardiovascular function, and anticipated difficult airway.

Design outcomes

Primary

Measure	Time frame
Cortisol;	—

Countries

China

Contacts

Public ContactChen XiaoBo

a15871583801@163.com+86 15871583801

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026